Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8(+) T and NK Cell Dependent Manner

Lignende værker

• SA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancer
  af: Srivastava, Abhishek K., et al.
  Udgivet: (2015)
• SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines
  af: Srivastava, Abhishek K., et al.
  Udgivet: (2014)
• SA-4-1BBL as a Novel Adjuvant for the Development of Therapeutic Cancer Vaccines
  af: Sharma, Rajesh K., et al.
  Udgivet: (2014)
• Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy
  af: Sharma, Rajesh Kumar, et al.
  Udgivet: (2010)
• SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model
  af: Sharma, Rajesh K., et al.
  Udgivet: (2010)